Pediatrix reported second-quarter earnings of $0.49 per share
Net revenue rose 4% to $488 million, Adjusted EBITDA $76 million, and the company reaffirmed its 2026 outlook.
See the latest news and media coverage for Pediatrix. We track all announcements, press releases, and industry mentions in real time, all in one place.
Provider of prenatal, neonatal, pediatric, and virtual care services
pediatrix.comLast updated
In short: Pediatrix posted Q2 revenue growth and reaffirmed its 2026 adjusted EBITDA outlook while expanding clinical services.
Net revenue rose 4% to $488 million, Adjusted EBITDA $76 million, and the company reaffirmed its 2026 outlook.
Net revenue was $476 million and adjusted EBITDA was $58 million. The company reaffirmed its 2026 outlook.
Net revenue of $493 million, net income of $72 million, and adjusted EBITDA of $87 million for the quarter. Adjusted EBITDA outlook raised to $270-$290 million.
The call at 9:00 a.m. ET on November 3 will discuss results for the quarter ended September 30, 2025.
The Pediatrix Medical Group stock (ISIN US6036761002) is characterized on 09/20/2026 by the latest quarterly figures and a noticeably critical analyst sentiment, after the US healthcare provider reported in its current interim report a...
MD posts 4% year-over-year revenue growth in the second quarter of 2026 despite lower patient volumes, aided by stronger reimbursement and acquisitions.
Detailed price information for Pediatrix Medical Group Inc (MD-N) from The Globe and Mail including charting and trades.
The MD stock of the US healthcare provider Pediatrix Medical Group Inc. (ISIN US59271J1051) is in the focus of investors on 08/28/2026 with a price of 26.81 US dollars, after according...
Track Pediatrix and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.